Relevance: GS Paper III – Science & Tech (Biotechnology, NCDs);
Source: The Hindu, global medical research
1. Immune-Free Bacterial Cancer Therapy
A Japanese research team has developed AUN Therapy, a novel cancer therapy that uses two engineered bacteria (Proteus mirabilis and Rhodopseudomonas palustris) to destroy tumour cells without relying on patient immunity.
- Selectively targets cancer cells and remodels tumour tissue.
- Avoids major side effects such as cytokine release syndrome.
- Especially useful for immunocompromised patients receiving chemo/radiotherapy.
UPSC Relevance: Part of emerging microbial oncology and precision biotherapeutics.
2. GLP-1 Weight-Loss Drugs & Cancer Risk Reduction
A new University of California study reports that GLP-1 agonists (e.g., Ozempic, Wegovy) nearly halve mortality in colorectal cancer patients.
Benefits arise from:
- Anti-inflammatory action
- Metabolic improvements
- Stronger effect in patients with obesity (BMI >35)
Clinical trials are underway to confirm if these drugs have a direct anti-cancer mechanism.
UPSC Relevance: Links obesity, metabolism and cancer; ties to India’s NPCDCS programme.
3. Gut Microbiome & Heart Disease
Research from Seoul identifies 15 gut bacteria strongly associated with coronary artery disease.
Key insights:
- Imbalanced gut microbes trigger inflammation and metabolic dysfunction.
- Even “good” bacteria like Faecalibacterium prausnitzii may become harmful in altered environments.
- Highlights the gut–heart axis in non-communicable diseases.
UPSC Relevance: Supports preventive health focus under Ayushman Bharat HWCs and growing interest in microbiome medicine.
UPSC Prelims Practice Question
Consider the following pairs:
- Cancer therapy – Immune-independent bacterial treatment
- Colorectal cancer – Reduced mortality linked to GLP-1 drugs
- Coronary artery disease – Linked to gut microbial imbalance
Which of the above pairs is/are correctly matched?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (d)
Share This Story, Choose Your Platform!
Start Yours at Ajmal IAS – with Mentorship StrategyDisciplineClarityResults that Drives Success
Your dream deserves this moment — begin it here.


